BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified GroupAs the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - diversified industry, including BD (
NYSEBDX) and its peers.
Surgical Equipment & Consumables - Diversified Stocks Q4 Highlights: CONMED (NYSE:CNMD)Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at CONMED (
NYSECNMD) and the best and worst performers in the surgical equipment & consumables - diversified industry.
CONMED Corporation Adds Mark Kaye to its Board of Directors
CONMED Corporation (
NYSECNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (
NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 24, 2025, payable on April 4, 2025, to all shareholders of record as of March 14, 2025.
CONMED (NYSE:CNMD) Beats Q4 Sales Targets But Stock DropsMedical tech company CONMED (
NYSECNMD) announced better-than-expected revenue in Q4 CY2024, with sales up 5.8% year on year to $345.9 million. On the other hand, the company’s full-year revenue guidance of $1.36 billion at the midpoint came in 2.7% below analysts’ estimates. Its non-GAAP profit of $1.34 per share was 11.4% above analysts’ consensus estimates.
CONMED Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results
CONMED Corporation (
NYSECNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2024.
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
CONMED Corporation (
NYSECNMD) today announced that it will report financial results for the fourth quarter 2024 after the market close on Wednesday, February 5, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
CONMED Corporation (
NYSECNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 4:30 p.m. PT (7:30 p.m. ET) on Monday, January 13, 2025 in San Francisco, CA.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (
NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 9, 2024, payable on January 3, 2025, to all shareholders of record as of December 20, 2024.
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat J. Beyer, Chief Operating Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 12:30 p.m. ET on Tuesday, December 3, 2024.
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 19-20
CONMED Corporation (
NYSECNMD) today announced that it will participate in fireside chats at the following two investor conferences in November:
CONMED Corporation Announces Third Quarter 2024 Financial Results
CONMED Corporation (
NYSECNMD) today announced financial results for the third quarter ended September 30, 2024.
CONMED Corporation Announces Leadership Succession
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman will retire as President and Chief Executive Officer (CEO) of the Company, effective January 1, 2025. Patrick Beyer, current Chief Operating Officer (COO) of CONMED, will succeed Mr. Hartman as President and CEO and will also be appointed as a member of the Company’s board, effective the same date.
CONMED Corporation Announces Preliminary Third Quarter Financial Information
As a follow up to the Current Report on Form 8-K issued by the Company on September 30, 2024, CONMED Corporation (
NYSECNMD) announced preliminary financial information for the third quarter of 2024. The Company expects revenue in the range of $315 million to $318 million and adjusted diluted net earnings per share growth in excess of its previously provided guidance of 9% to 11%.
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 22nd Annual Best Ideas Conference at 10:15 a.m. ET on Monday, September 16, 2024.
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 8:00 a.m. ET on Wednesday, September 4, 2024.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (
NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 8, 2024, payable on October 4, 2024, to all shareholders of record as of September 16, 2024.
